The 2017 U.S. In-Vitro Diagnostic Substance Manufacturing-Industry and Market Report, published annually by Barnes Reports, contains timely and accurate industry statistics, forecasts and demographics.
The report features 2017 current and 2018 forecast estimates on the size of the industry (sales, establishments, employment) nationally and for all 50 U.S. States and over 900 metro areas. Other data include financial ratios, number of firms, payroll, industry definition, 5-year historical trends on industry sales, establishments and employment, a breakdown of establishments, sales and employment by employee size of establishment (9 categories), and estimates on up to 10 sub-industries, including plasmas, serums, allergens, vaccines and other immunizing products, blood derivatives, and culture media.
This industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices.
Barnes Reports' Industry & Market reports are an essential part of any GAP analysis, benchmarking project, SWOT analysis, business plan, risk analysis, or growth-share matrix.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook